Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Manufacture and Supply of Dibucaine Ointment (1%)

Active

Federal

Response Deadline07/28/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract solicits the manufacture and supply of Dibucaine Ointment USP at a 1% concentration, packaged in 28g collapsible tubes equipped with rectal applicators, intended for external use and in full compliance with USP and FDA cGMP standards. The product must meet all applicable pharmaceutical specifications for quality, safety, and consistency, with packaging designed to ensure proper delivery and patient usability. Production and delivery are subject to strict regulatory adherence, and the supplier is expected to maintain documentation and quality controls that satisfy federal pharmaceutical manufacturing requirements. The solicitation is issued under the NAICS code 325412 for pharmaceutical preparation manufacturing and is classified as a subcontract within the Department of Defense’s Medical Supply Chain Pharm FSA. The response deadline is July 28, 2026, with the contract set to be awarded following evaluation of submissions received by that date. The place of performance is designated as FPO, ZIP 34089, and the opportunity is accessible through the DIBBS platform at the provided URL. All bidders must ensure their proposals align with the technical specifications and regulatory compliance outlined in the solicitation to be considered for award.

General Info

Manufacture and supply 1% Dibucaine Ointment USP in 28g tubes with applicators, compliant with USP/FDA cGMP, for DoD delivery by July 28, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FPO, AA, 34089, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 22

subcontract

Response DeadlineJul 28

Submission deadline

Response Deadline

07/28/2026, 05:00:00 PM UTCin 5 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supply of Dibucaine Ointment USP, 1% concentration, in 28g collapsible tubes with rectal applicators, compliant with USP and FDA cGMP standards for external use.

Similar Contracts

Same NAICS industry code

Medical Supply Procurement – Spinal Anesthesia Kits with PharmaceuticalsThe contract seeks the supply of pre-packaged spinal anesthesia kits, each containing a 25-gauge by 3.5-inch Quincke-type spinal needle and bupivacaine, fully compliant with FDA manufacturing, labeling, and packaging standards. The kits must be produced and assembled to meet stringent medical and regulatory requirements to ensure safety, sterility, and consistency for clinical use. All components must be integrated into a single, ready-to-use system designed for reliable performance in surgical settings, with labeling that clearly identifies contents, batch information, expiration dates, and usage instructions in accordance with federal guidelines. The procurement is issued as a subcontract under the Department of Defense's Medical Supply Chain, specifically managed by the MEDICAL SUPPLY CHAIN MD SURG FSF, with performance required at the Hampton, Virginia location identified by zip code 23665-2040. The solicitation, posted on July 22, 2026, has a response deadline of July 28, 2026, and falls under NAICS code 325412 for pharmaceutical and medicine manufacturing. Suppliers must be prepared to meet military-grade logistics and quality control expectations, with an emphasis on timely delivery, traceability, and full compliance with defense procurement protocols.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Pharmaceutical Supply – Iopamidol Injection (ISOUE-370)The contract solicits the supply of 100 mL single-dose bottles of Iopamidol Injection (ISOUE-370), packaged in tens per package, in strict compliance with the National Stock Number 6505016570664 specifications. The product is intended for medical use and must meet all relevant pharmaceutical and packaging standards required by the Department of Defense. The solicitation is issued under the NAICS code 325412, indicating it pertains to pharmaceutical preparation manufacturing, and is classified as a subcontract under the Medical Supply Chain Pharm FSA, a division within the Department of Defense. The opportunity was posted on July 22, 2026, with responses due by July 28, 2026, providing a six-day window for potential suppliers to submit proposals. The place of performance and point of contact details are not specified, but the solicitation can be accessed via the DIBBS portal using the provided link. The contract does not indicate any specific set-aside status, meaning it is open to all qualified vendors without preference for small, veteran-owned, or other designated business categories. Delivery and compliance with the exact NSN standards are paramount for award consideration.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical Diagnostic Kit Supply – Blood Cell Counting KitThe contract calls for the supply of a complete blood cell counting kit tailored for erythrocyte counting, encompassing all necessary reagents and consumables required for accurate and reliable diagnostic use. The kit must fully comply with FDA regulations and Department of Defense labeling and shelf-life standards, ensuring suitability for military medical operations and long-term storage under varied conditions. All components must meet stringent quality and safety benchmarks to guarantee performance in field and clinical environments. The solicitation is issued under the NAICS code 325412 for pharmaceutical and medicinal preparation manufacturing and is classified as a subcontract. It is managed by the Department of Defense through the Medical Supply Chain MD Surg FSF, with performance required at Hampton, Virginia, 23665-2040. Interested parties must submit responses by July 28, 2026, and the opportunity was posted on July 22, 2026, through the DIBBS system. While the set-aside type is unspecified, the procurement is structured to support defense medical readiness through reliable diagnostic tooling.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Pharmaceutical Supply and DistributionThe contract is for the supply and delivery of FDA-regulated Lidocaine Hydrochloride and Epinephrine (USP) in 1.7 mL cartridges, packaged 50 per unit, to Joint Base Elmendorf-Richardson, Alaska, under the National Stock Number 6505-01-576-2767. The product must meet all federal pharmaceutical standards and be delivered under FOB Destination terms, ensuring the vendor assumes responsibility for transportation and risk until the goods reach the指定 location. The contract is classified as a subcontract within the NAICS code 325412 for pharmaceutical preparation manufacturing, issued by the Department of Defense through the Medical Supply Chain Pharm FSA. Responses are required by July 28, 2026, with the solicitation posted on July 22, 2026, indicating a narrow six-day window for submissions. The place of performance is clearly identified as JBER with ZIP code 99506-4400, and all deliveries must align with military supply specifications. The contract is managed through the DLA Dibbs platform, requiring vendors to engage through the official portal to submit proposals. There is no set-aside designation specified, meaning all eligible contractors may compete without restrictions based on business size or category.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Hydrogen Peroxide Topical Solution (NSN 6505001538480)The contract requires the manufacture and supply of a 3% Hydrogen Peroxide Topical Solution designated by NSN 6505001538480, to be produced and delivered in full compliance with FDA, OSHA, and military labeling standards. The product must be delivered to Camp Beauregard, Louisiana, no later than 20 days after order placement, ensuring timely availability for medical use. The solicitation is issued under the Department of Defense’s Medical Supply Chain PHSA and is classified as a subcontract, with the NAICS code 325412 indicating pharmaceutical and biological product manufacturing. The response deadline is set for July 28, 2026, and the place of performance is listed as Morrisville, North Carolina, with a zip code of 27560-0000, suggesting the supplier may be expected to maintain operations or distribution from that location despite the final delivery destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical Diagnostic Test Strip ManufacturingThe contract seeks the manufacture of sterile Fluorescein Sodium Ophthalmic Strips intended for corneal diagnostic applications, with strict adherence to FDA regulations, current Good Manufacturing Practices, and Defense Logistics Agency standards. The product must meet exacting quality and sterility requirements to ensure safe and effective use in clinical settings, particularly within military and government health care environments. Manufacturing must occur in compliance with all applicable regulatory frameworks, ensuring traceability, documentation integrity, and consistent batch quality throughout production. The solicitation, classified as a subcontract under NAICS code 325412, is issued by the Department of Defense through the Medical Supply Chain Pharm FSA and specifies Fort Bliss, Texas, with ZIP code 79918-2527 as the place of performance. Interested parties must submit responses by the deadline of July 28, 2026, with the opportunity to participate initiated on July 22, 2026. While no set-aside designation is specified, the procurement is managed through the DLA's DIBBS platform, indicating its alignment with federal defense supply chain protocols and requiring full compliance with all contractual and logistical expectations tied to DoD procurement practices.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Manufacture and Supply of Chlorine Test Tablets (DPD NO. 1R)The contract calls for the manufacture and supply of chlorine test tablets that meet FDA compliance standards and are formulated to DPD NO. 1R specifications, ensuring accurate and reliable chlorine detection in water testing applications. The tablets must have a shelf life of 36 months and undergo rigorous batch testing to guarantee consistency, potency, and adherence to technical requirements. All products must be packaged in units of 100 tablets, with packaging designed to maintain stability and integrity throughout storage and distribution. The contract is issued as a subcontract under the Department of Defense’s Medical Supply Chain MD SURG FSF, with performance required at a designated location in Hampton, Virginia, zip code 23665-2040. The solicitation was posted on July 22, 2026, and responses are due by July 28, 2026, providing a limited window for qualified vendors to submit proposals. The NAICS code 325412 indicates the work falls under pharmaceutical and medicine manufacturing, emphasizing the need for production in a controlled environment that supports medical-grade quality assurance. The procurement is part of a broader effort to ensure reliable water safety monitoring capabilities within Department of Defense medical and field operations.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Chloride Quantab Test Strips (High Range)The contract is for the procurement and delivery of high-range chloride test strips capable of measuring concentrations between 300 and 6000 mg/L, packaged in bottles containing 40 strips each. All products must fully comply with DLA medical standards governing packaging, labeling, and shelf life to ensure reliability and safety in medical supply chain applications. The solicitation is classified as a subcontract under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF under the Department of Defense. Performance is required at the designated location in Hampton, Virginia, with a zip code of 23665-2040. The opportunity was posted on July 22, 2026, and responses are due by July 28, 2026, with all submissions expected to meet the technical and regulatory requirements outlined by the agency.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

ZINC OXIDE OINTMENTZinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, is provided in collapsible tubes of 28.35 grams, with the unit of issue designated as a tube (TU). The product is regulated by the FDA and must comply with strict technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, including packaging standards under MIL-STD-129 and commercial packaging per ASTM D3951 when non-hazardous, with DLA requirements superseding all other standards. Labeling must adhere to the latest Medical Marking Standard No. 1, and shelf life is fixed at 36 months without extension. Storage requires controlled room temperature not exceeding 30°C (86°F). The ointment is supplied by DYNAREX CORP under NDC 67777-0223-11 and part number 1190, with traceable shipping mandated and parcel post prohibited. Two delivery lines are specified: three tubes to Morrisville, NC with a July 24, 2026 delivery deadline and six tubes to Fort Bragg, NC with a July 27, 2026 deadline, both delivered FOB destination with zero quantity variance permitted. Inspection and acceptance occur at the delivery point, and packaging must meet DLA's RP001 packaging and palletization requirements. All shipments must include government-identifying information per contract specifications and be tracked through authenticated logistics channels.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MULTIPLE ELECTROLYTThe contract specifies the procurement of Multiple Electrolytes Injection, Type 1, USP, in 500 mL bags, packaged in units of 24 per package, with a required shelf life of 18 months. No more than three months may have elapsed between the date of manufacture and the date of delivery to the government. The product is regulated by the FDA and must meet all applicable technical and quality requirements as defined in the DLA Master List of Technical and Quality Requirements, with packaging and marking strictly compliant with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a suitable container to prevent damage, and shipping containers must ensure safe, low-cost delivery to the point of delivery at Fort Bliss, Texas, with inspection and acceptance occurring at the destination. The item is identified by NSN 6505-01-462-5414 and manufacturer part number NDC00338-0221-03, produced by Baxter Healthcare Corp. The contract requires delivery within 20 days under FOB destination terms with zero variance allowed in quantity. The solicitation is issued under SPE2DP-26-T-4243 with a response deadline in July 2026, and the unit of issue is PG (package of 24), aligned to the DoD authorized unit. Additional provisions include handling of covered defense information and compliance with DLA’s packaging and labeling standards for medical acquisitions.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

FLUCONAZOLE TABLETSFluconazole Tablets 150 mg are supplied in individually sealed blister strips containing 12 tablets per strip, with the unit of issue defined as a package. The product must have a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of delivery to the government. Packaging must comply with commercial standards and be designed to protect the contents from damage or breakage, with exterior shipping containers suitable for safe transport at the lowest possible freight rate. All items must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and mercury or mercury-containing compounds are strictly prohibited from intentional addition or direct contact with the supply except under specific exceptions for functional components like batteries or instruments, which must meet additional containment and shockproof requirements. The National Stock Number is 6505013953039, and the contract is issued under solicitation SPE2DP-26-T-4241 with delivery required FOB destination within 20 days. The quantity ordered is one package with zero variance allowed, and inspection and acceptance occur at the delivery point. The manufacturer identified is Golden State Medical Supply, Inc. with NDC 51407-0426-12, and ANIP Acquisition Co with NDC 62559-0992-12. Applicable technical and quality requirements are referenced from the DLA Master List, and the contract falls under the NAICS code 325412 for pharmaceutical manufacturing.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DIBUCAINE OINTMENTDIBUCAINE OINTMENT USP, containing 1 percent dibucaine as the active ingredient, is supplied in a collapsible tube with a rectal applicator and is intended for rectal administration only, classified for external use. Each unit of issue is a single package containing one ounce or 28 grams of the ointment, with a non-extendable shelf life of 36 months and storage requirements between 15 and 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is FDA-regulated and must comply with the DLA Master List of Technical and Quality Requirements, including MIL-STD-129 for marking and labeling, and packaging must adhere to RP001 for DLA procurement standards, with materials either packaged per IP025 if hazardous or ASTM D3951 if not, prioritizing DLA specifications over commercial standards. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, with a unit of issue in packages and quantity per unit pack of one. The contract SPE2DP-26-T-4234 specifies four separate line items totaling 11 packages, each priced at $2.00, with delivery due within 20 days of order, FOB destination, zero quantity variance allowed, and inspection and acceptance occurring at the delivery point. Shipments are directed to four distinct U.S. Navy vessel addresses in FPO locations, with explicit instructions to avoid parcel post and use only traceable freight methods via VSM. Required delivery dates span from May 29, 2026, to July 24, 2026, with specific RDD codes and project identifiers linked to each delivery. The product must be procured from the HARVARD DRUG GROUP, L.L.C., and all packaging, labeling, and shipping must strictly follow DLA technical and quality directives, including medical marking standards and palletization requirements, ensuring full compliance with federal procurement protocols.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Commercial Barcoding and Data Labeling ServicesThe contract requires the application of commercial barcodes and PKGING DATA elements such as QUP, PRES MTHD, and WRAP MAT to shipping units in strict compliance with MIL-STD-2073-1E standards and established commercial best practices. This work ensures accurate identification, tracking, and handling of medical supply units throughout the defense supply chain by integrating standardized data elements into labeling systems. The scope centers on the precise implementation of labeling protocols that support logistics efficiency, inventory accuracy, and regulatory compliance for defense medical shipments. This subcontract is issued under NAICS code 561910 and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 22, 2026, with a response deadline of July 28, 2026. Although no specific place of performance or point of contact is listed, the work pertains to activities supporting DoD medical logistics operations. Interested parties must submit responses through the provided DIBBS link prior to the deadline to be considered for award.

Packaging and Labeling Services

POSTED

DEADLINE

International Medical Supply Logistics and FOB Destination DeliveryThe contract requires the arrangement and execution of international shipments of medical supplies from locations in the United States to Yokota Air Base in Japan, with delivery terms specified as FOB Destination, meaning the seller assumes all costs and risks until the goods arrive at the designated destination. The selected carrier must be the lowest-cost common carrier capable of reliably transporting the supplies, with full compliance to international shipping regulations and proper documentation, including export declarations, customs forms, and tracking information. All logistics activities must ensure the integrity, security, and timely delivery of sensitive medical materials under strict regulatory standards. The solicitation is classified as a subcontract under NAICS code 488999, which covers other support activities for transportation, and is issued by the Department of Defense through the MEDICAL SUPPLY CHAIN PHARM FSA. The opportunity was posted on July 22, 2026, with a response deadline of July 28, 2026, indicating a brief window for interested parties to submit proposals. While specific performance locations and point of contact details are not provided, the place of performance is clearly defined as Yokota Air Base, Japan, and the contract emphasizes cost efficiency, regulatory compliance, and seamless end-to-end logistics coordination without compromise to shipment safety or documentation accuracy.

All Other Support Activities for Transportation

POSTED

DEADLINE

Hazardous Materials Packaging and Labeling ComplianceThe contract requires strict compliance with OSHA and military standards for the packaging and labeling of Iopamidol Injection as a hazardous material, ensuring all shipments meet stringent safety and regulatory requirements. All packages must be durably labeled with the National Stock Number, Contract Line Item Number, exact quantity, delivery point, and clear hazard warnings to facilitate safe handling and transport throughout the supply chain. This subcontract, issued under NAICS code 561910 by the Department of Defense’s Medical Supply Chain Pharm FSA, mandates accurate and durable labeling as a condition of performance, with proposals due by July 28, 2026. The work involves adherence to federal hazardous materials regulations and military logistics protocols, with no specified place of performance details provided, implying flexibility in execution as long as compliance standards are met. All parties must ensure full alignment with DOD procurement and safety directives to qualify for award.

Packaging and Labeling Services

POSTED

DEADLINE

Quality Assurance and Regulatory Compliance SupportThe contract seeks independent testing and certification services to ensure pharmaceutical packaging and product quality meet stringent regulatory standards, including DLA, MIL-STD-129, and FED-STD-313, among others. The scope requires rigorous verification of compliance to support the Department of Defense’s medical supply chain, with performance focused on ensuring that all packaging systems and product labeling adhere to military and federal specifications for durability, traceability, and safety. The work must be performed by a qualified subcontractor capable of delivering certified results under strict timelines and regulatory oversight. This subcontract is posted under NAICS code 541380, indicating it falls under professional, scientific, and technical services for measurement, testing, and analysis. The response deadline is set for July 28, 2026, with the contract anticipated to support operations centered at FPO, zip code 34089. Although the point of contact and agency office details are unspecified, the solicitation is managed by the Medical Supply Chain Pharm FSA under the Department of Defense, emphasizing the critical nature of quality assurance for military pharmaceutical logistics. The offering is not subject to any set-aside provisions and is accessible to eligible subcontractors seeking to fulfill essential compliance obligations for defense healthcare systems.

Testing Laboratories and Services

POSTED

DEADLINE

Domestic and International Logistics to Military VesselsThis contract involves the domestic and international transportation and delivery of pharmaceuticals to U.S. military vessels operating at Fleet Post Office addresses, with full responsibility for all risks and costs of transport assumed by the contractor under FOB Destination terms. The work requires reliable logistics coordination to ensure timely, secure, and compliant delivery of sensitive medical supplies to mobile military locations, regardless of geographic complexity or operational constraints. The contractor must manage end-to-end shipping processes, including customs clearance, tracking, and documentation, to meet the stringent requirements of military healthcare operations. The solicitation was posted on July 22, 2026, with responses due by July 28, 2026, and falls under the NAICS code 483111 for ocean transportation of freight. It is structured as a subcontract and is issued by the Department of Defense through the Medical Supply Chain Pharm FSA, with the place of performance identified as FPO with a zip code of 34089. All logistics must adhere to military standards and regulatory protocols for pharmaceutical handling, ensuring product integrity and accountability throughout the supply chain. The contractor must be prepared to operate under high-security protocols and respond to dynamic delivery schedules dictated by vessel movements and mission requirements.

Deep Sea Freight Transportation

POSTED

DEADLINE

Hazardous Materials Packaging and LabelingThe contract requires the packaging and labeling of Dibucaine Ointment in strict adherence to military and federal hazardous material regulations, specifically conforming to MIL-STD-129 and TQ Requirement IP025, ensuring all materials meet the rigorous standards for handling, marking, and documenting hazardous pharmaceutical products within the defense supply chain. This subcontract is part of a broader effort by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA to maintain operational readiness by securing properly labeled and compliant medical supplies for deployment and use in military operations. The work must be performed under the place of performance designated as FPO with a zip code of 34089, and all deliverables must align with the North American Industry Classification System code 325998, which pertains to other pharmaceutical and medicine manufacturing. Responses to this solicitation are due by July 28, 2026, and the posting date is July 22, 2026, indicating a very limited window for submission. The contract is classified as a subcontract and does not specify a set-aside type, meaning it is open to eligible contractors without preference or restriction. All parties must ensure full compliance with hazardous material protocols and documentation requirements to avoid rejection or non-compliance penalties.

All Other Miscellaneous Chemical Product and Preparation Manufacturing

POSTED

DEADLINE

Hazardous Material Compliance and Safety DataThe contract requires full compliance with hazard communication standards for epinephrine-containing pharmaceuticals, mandating accurate generation of Safety Data Sheets and proper labeling in accordance with OSHA’s 29 CFR 1910.1200 and DFARS requirements. All deliverables must align with federal regulations governing the safe handling, storage, and dissemination of hazardous chemical information, ensuring that personnel and facilities are properly informed of risks associated with these pharmaceuticals. The work is scoped as a subcontract under NAICS code 541620, targeting specialized scientific and technical services related to regulatory compliance and pharmaceutical safety. Performance is to be conducted at Joint Base Elmendorf-Richardson, Alaska, with the solicitation issued by the Department of Defense through the Medical Supply Chain Pharm FSA. Proposals are due by July 28, 2026, and the contracting vehicle is accessible via the DIBBS platform. While no specific set-aside designation is indicated, the requirement emphasizes strict adherence to federal safety protocols and accurate documentation, reflecting the critical nature of hazard communication for life-saving medications in military and defense supply operations.

Environmental Consulting Services

POSTED

DEADLINE

DoD Medical Item Labeling and BarcodingThe contract requires the application of standardized labels and 2D Data Matrix barcodes to medical shipments and unit packs to comply with the Department of Defense’s Medical Marking Standard No. 1, ensuring accurate tracking and logistics across the military supply chain. This work is critical for maintaining visibility and accountability of medical supplies in theater and within domestic logistics networks, with precise adherence to labeling specifications mandated by the DoD. The performance location is specified as JBER, Alaska, with a zip code of 99506-4400, indicating the physical site where labeling and barcoding operations must be executed. This is a subcontract opportunity under NAICS code 323111, which pertains to commercial printing services, and is managed by the Medical Supply Chain Pharm FSA under the Department of Defense. The solicitation was posted on July 22, 2026, with responses due by July 28, 2026, indicating a short window for potential vendors to submit proposals. The contract aims to support defense medical logistics through reliable, compliant marking practices, and all work must align strictly with DoD requirements to ensure seamless integration into existing tracking systems.

Commercial Printing (except Screen and Books)

POSTED

DEADLINE

DoD-Compliant Medical Packaging and PreservationThe contract requires the supply of sealed unit containers and preservation packaging that meet stringent military standards, specifically MIL-STD-2073-1E and the Medical Marking Standard No. 1, to ensure the protection and integrity of medical items throughout transport and long-term storage. All packaging must be designed and manufactured to withstand environmental stresses and maintain sterility, operational readiness, and traceability under Department of Defense protocols. The items are intended for use in critical medical supply chains where failure to comply with specifications could compromise mission readiness and patient safety. This is a subcontract opportunity issued by the Department of Defense under the Medical Supply Chain Pharm FSA, with performance required at JBER, Alaska, 99506-4400. The North American Industry Classification System code 323113 applies, indicating the work involves custom computer programming and related services tied to packaging systems. Respondents must submit proposals by the deadline of July 28, 2026, and all submissions must align precisely with the technical and labeling requirements outlined in the referenced standards. The solicitation is open to qualified subcontractors capable of delivering compliant, high-integrity packaging solutions under strict defense logistics guidelines.

Commercial Screen Printing

POSTED

DEADLINE

Small Business and Socioeconomic Certification SupportThe contract seeks consulting services to assist small businesses in obtaining and maintaining certifications critical for government contracting, including Women-Owned Small Business, Economically Disadvantaged Women-Owned Small Business, Service-Disabled Veteran-Owned Small Business, and HUBZone certifications, as well as ensuring compliance with the nonmanufacturer rule. These services are essential for businesses aiming to compete for federal procurement opportunities, particularly within the Department of Defense, and require expert guidance to navigate complex eligibility criteria, documentation, and ongoing compliance requirements. The work must be performed in Morrisville, North Carolina, with a response deadline of July 28, 2026, and is structured as a subcontract under NAICS code 541611 for management consulting services. The agency responsible is the Medical Supply Chain Pharm FSA under the Department of Defense, and the opportunity is accessible via the DIBBS platform.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE